Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for Codeine Therapy in the Context of Cytochrome P450 2D6 (CYP2D6) Genotype von Crews, K R, Gaedigk, A, Dunnenberger, H M, Klein, T E, Shen, D D, Callaghan, J T, Kharasch, E D, Skaar, T C

Volltext

Clinical Pharmacogenetics Implementation Consortium Guidelines for Cytochrome P450 2D6 Genotype and Codeine Therapy: 2014 Update von Crews, K R, Gaedigk, A, Dunnenberger, H M, Leeder, J S, Klein, T E, Caudle, K E, Haidar, C E, Shen, D D, Callaghan, J T, Sadhasivam, S, Prows, C A, Kharasch, E D, Skaar, T C

Volltext

Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C9 and HLA-B Genotypes and Phenytoin Dosing von Caudle, K E, Rettie, A E, Whirl-Carrillo, M, Smith, L H, Mintzer, S, Lee, M T M, Klein, T E, Callaghan, J T

Volltext

Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for human leukocyte antigen B (HLA-B) genotype and allopurinol dosing: 2015 update von Saito, Y, Stamp, LK, Caudle, KE, Hershfield, MS, McDonagh, EM, Callaghan, JT, Tassaneeyakul, W, Mushiroda, T, Kamatani, N, Goldspiel, BR, Phillips, EJ, Klein, TE, Lee, MTM

Volltext

Clinical Pharmacogenetics Implementation Consortium Guidelines for Human Leukocyte Antigen-B Genotype and Allopurinol Dosing von Hershfield, M S, Callaghan, J T, Tassaneeyakul, W, Mushiroda, T, Thorn, C F, Klein, T E, Lee, M T M

Volltext

Implementation of a pharmacogenomics consult service to support the INGENIOUS trial von Eadon, MT, Desta, Z, Levy, KD, Decker, BS, Pierson, RC, Pratt, VM, Callaghan, JT, Rosenman, MB, Carpenter, JS, Holmes, AM, McDonald, CA, Benson, EA, Patil, AS, Vuppalanchi, R, Gufford, BT, Dave, N, Robarge, JD, Hyder, MA, Haas, DM, Kreutz, RP, Dexter, PR, Skaar, TC, Flockhart, DA

Volltext

Confidence interval criteria for assessment of dose proportionality von SMITH, Brian P, VANDENHENDE, Francois R, DESANTE, Karl A, FARID, Nagy A, WELCH, Pamela A, CALLAGHAN, John T, FORGUE, S. Thomas

Volltext

Olanzapine : pharmacokinetic and pharmacodynamic profile von CALLAGHAN, J. T, BERGSTROM, R. F, PTAK, L. R, BEASLEY, C. M

Volltext

The physical properties and response of osteoblasts to solution cast films of PLGA doped polycaprolactone von Tang, Z.G., Callaghan, J.T., Hunt, J.A.

Volltext

QT Effects of Duloxetine at Supratherapeutic Doses: A Placebo and Positive Controlled Study von Zhang, Lu, Chappell, Jill, Gonzales, Celedon R, Small, David, Knadler, Mary P, Callaghan, JT, Francis, Jennie L, Desaiah, Durisala, Leibowitz, Mark, Ereshefsky, Larry, Hoelscher, David, Leese, Philip T, Derby, Michael

Volltext

The design and production of Co–Cr alloy implants with controlled surface topography by CAD–CAM method and their effects on osseointegration von Hunt, John Alan, Callaghan, Jill T., Sutcliffe, Chris J., Morgan, Rhys H., Halford, Ben, Black, Richard A.

Volltext

The Effects of Supratherapeutic Doses of Duloxetine on Blood Pressure and Pulse Rate von Derby, Michael A, Zhang, Lu, Chappell, Jill C, Gonzales, Celedon R, Callaghan, J T, Leibowitz, Mark, Ereshefsky, Larry, Hoelscher, David, Leese, Philip T, Mitchell, Malcolm I

Volltext

Olanzapine: Interaction Study with Imipramine von Callaghan, John T., Cerimele, Benito J., Kassahun, Kelem J., Nyhart Jr, Eldon H., Hoyes-Beehler, Pamela J., Kondraske, George V.

Volltext

Lack of Effect of Olanzapine on the Pharmacokinetics of a Single Aminophylline Dose in Healthy Men von Macias, William L., Bergstrom, Richard E, Cerimele, Benito J., Kassahun, Kelem, Tatum, David E., Callaghan, John T.

Volltext

Role of serum prolactin determination in evaluation of impotent patient von Foster, R.S., Mulcahy, J.J., Callaghan, J.T., Crabtree, R., Brashear, D.

Volltext

Multilayer Nanoscale Encapsulation of Biofunctional Peptides to Enhance Bone Tissue Regeneration In Vivo von Gentile, Piergiorgio, Ferreira, Ana Marina, Callaghan, Jill T., Miller, Cheryl A., Atkinson, Joss, Freeman, Christine, Hatton, Paul V.

Volltext

Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington's disease in the TRACK-HD study: analysis of 36-month observational data von Tabrizi, Sarah J, Prof, Scahill, Rachael I, PhD, Owen, Gail, PhD, Durr, Alexandra, MD, Leavitt, Blair R, MDCM, Roos, Raymund A, Prof, Borowsky, Beth, PhD, Landwehrmeyer, Bernhard, Prof, Frost, Chris, Prof, Johnson, Hans, PhD, Craufurd, David, MD, Reilmann, Ralf, MD, Stout, Julie C, Prof, Langbehn, Douglas R, Prof

Volltext

Identification of genetic variants associated with Huntington's disease progression: a genome-wide association study von Moss, Davina J Hensman, MBBS, Pardiñas, Antonio F, PhD, Langbehn, Douglas, Prof, Lo, Kitty, PhD, Leavitt, Blair R, Prof, Roos, Raymund, Prof, Durr, Alexandra, Prof, Mead, Simon, Prof, Holmans, Peter, Prof, Jones, Lesley, Prof, Tabrizi, Sarah J, Prof

Volltext

Biological and clinical changes in premanifest and early stage Huntington's disease in the TRACK-HD study: the 12-month longitudinal analysis von Tabrizi, Sarah J, Prof, Scahill, Rachael I, PhD, Durr, Alexandra, MD, Roos, Raymund AC, MD, Leavitt, Blair R, FRCPC, Jones, Rebecca, MSc, Landwehrmeyer, G Bernhard, MD, Fox, Nick C, MD, Johnson, Hans, PhD, Hicks, Stephen L, PhD, Kennard, Christopher, FRCP, Craufurd, David, FRCPsych, Frost, Chris, PhD, Langbehn, Douglas R, MD, Reilmann, Ralf, MD, Stout, Julie C, PhD

Volltext

Potential endpoints for clinical trials in premanifest and early Huntington's disease in the TRACK-HD study: analysis of 24 month observational data von Tabrizi, Sarah J, Prof, Reilmann, Ralf, MD, Roos, Raymund AC, MD, Durr, Alexandra, MD, Leavitt, Blair, FRCP, Owen, Gail, PhD, Jones, Rebecca, MSc, Johnson, Hans, PhD, Craufurd, David, FRCPsych, Hicks, Stephen L, PhD, Kennard, Christopher, FRCP, Landwehrmeyer, Bernhard, MD, Stout, Julie C, PhD, Borowsky, Beth, PhD, Scahill, Rachael I, PhD, Frost, Chris, MA, Langbehn, Douglas R, PhD

Volltext